Seiichiro Kusuhara
Sagamihara, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Differential predictive value of baseline tumor size according to PD-L1 expression in advanced NSCLC treated with immune checkpoint inhibitors.
Journal: Cancer treatment and research communications
Published: September 18, 2025
A Feasibility Randomized Controlled Trial of Nurse-Led Screening-Based Early Care Program from the Time of Diagnosis for Patients with Advanced Lung Cancer and Their Caregivers.
Journal: Palliative medicine reports
Published: April 07, 2025
Combination carboplatin and nab-paclitaxel as a first-line treatment for advanced thymic carcinoma.
Journal: Investigational new drugs
Published: May 17, 2022
First-line osimertinib for poor performance status patients with EGFR mutation-positive non-small cell lung cancer: A prospective observational study.
Journal: Investigational new drugs
Published: October 12, 2021
A Prospective Observational Study of Osimertinib for Chemo-Naive Elderly Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer.
Journal: Cancer management and research
Published: September 22, 2021
Prognostic significance of galectin-3 expression in patients with resected NSCLC treated with platinum-based adjuvant chemotherapy.
Journal: Thoracic cancer
Published: February 12, 2021
Prognostic significance of NAP1L1 expression in patients with early lung adenocarcinoma.
Journal: Biomedical research (Tokyo, Japan)
Published: June 12, 2020
Real-world assessment of afatinib for patients with EGFR-positive non-small cell lung cancer.
Journal: Investigational new drugs
Published: April 23, 2020
TRAP1 is a predictive biomarker of platinum-based adjuvant chemotherapy benefits in patients with resected lung adenocarcinoma.
Journal: Biomedical research (Tokyo, Japan)
Published: February 25, 2020
Impact of neutrophil-to-lymphocyte ratio in patients with EGFR-mutant NSCLC treated with tyrosine kinase inhibitors.
Journal: Investigational new drugs
Published: February 17, 2020
Current status and progress of concurrent chemoradiotherapy in patients with locally advanced non-small cell lung cancer prior to the approval of durvalumab.
Journal: Thoracic cancer
Published: November 12, 2019
Prognostic significance of IMMT expression in surgically-resected lung adenocarcinoma.
Journal: Thoracic cancer
Published: July 16, 2019
Last Updated: 09/26/2026